The US health regulator has pulled up Granules India for failing to maintain buildings for drug storage and avoiding adequate procedures regarding cleaning and maintenance of equipment at its ...

The U.S. Food and Drug Administration (U.S. FDA) has issued a warning letter to generic drugmaker Granules India’s finished dosages and pharmaceutical formulation intermediates manufacturing ...

Drug firm Granules India Ltd on Thursday (February 27) announced that the US FDA has issued a Warning Letter for its Gagillapur facility following an inspection conducted in August 2024. "On February ...

Granules India Ltd has received a Warning Letter from the US Food and Drug Administration (FDA) for its Gagillapur facility, following an inspection conducted in August 2024. The pharmaceutical ...